17 May, 2026
Stockholmsmässan, Stockholm, Sweden
❋
ESTRO2026 MAMMOKNIFE Lunch Symposium
What to ExpectProne Radiotherapy, Modernized
An Exclusive Satellite Symposium at ESTRO Annual Congress 2026
Join us Sunday, May 17 | 13:00 – 14:00 Lunch
Room: Viktoria | Stockholmsmassan, Stockholm, Sweden
❋ Why attendBreast radiotherapy is evolving, but are current techniques keeping up with clinical needs?
Join leading experts for a focused, high-impact session exploring how prone positioning is being redefined to improve precision, workflow, and patient outcomes.
This is not just another lecture, it’s a discussion on where breast radiotherapy is headed next.
You’ll walk away with:
Insight into emerging clinical approaches and technology innovation
Expert perspectives from leaders shaping the future of breast cancer treatment
A first look at a novel solution designed to rethink the standard of care
❋ Featured SpeakersMichael Dominello, DO Karmanos Cancer Institute, USA (Chair & Lead Speaker)
Stefan Ueltzhöffer
CEO - gKteso GmbH, Germany
Michael Teicher
CEO - MAMMOKNIFE, USA
❋ Event DetailsThis satellite symposium will take place onsite during the ESTRO Annual Congress 2026 in Stockholm, held in Room Viktoria at the congress venue.
Scroll down to view the full agenda and featured speaker line-up.
Please note that seating is limited, and refreshments will be available on a first-come, first-served basis. We encourage early arrival to ensure your participation. We look forward to welcoming you for an engaging session focused on advancing the future of breast radiotherapy.
Register now to reserve your seat and be part of the conversation shaping the future of breast radiotherapy.
AgendaProne Radiotherapy, Reimagined
Join us for lunch. Expect a balance of thought leadership and practical relevance, with time built in for discussion so you can engage directly with the experts and explore what these advancements mean for your own clinical practice.
13:00 – 13:05Welcome & Introduction
Michael Teicher, CEO, MAMMOKNIFE, USA
13:05 – 13:30Prone Radiotherapy Modernized:
Clinical Rationale & Unmet Needs
Michael Dominello, DO
Karmanos Cancer Institute, USA
13:30 – 13:45Rethinking Prone Breast Radiotherapy:
The MAMMOKNIFE Approach
Stefan Ueltzhöffer, CEO
gKteso GmbH, Germany
13:45 – 13:55Open Discussion & Expert Perspectives
Led by Michael Dominello, DO
13:55 – 14:00Closing Remarks
Michael Teicher, CEO, MAMMOKNIFE, USA
